International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
February 13, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
January 03, 2019 11:10 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
December 18, 2018 09:25 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies...
Global Traumatic Brain Injuries Treatment Market, Improving Quality of Life and Boosting the Healthcare Business is Expected to Reach USD 156.8 Billion by 2024
November 20, 2018 06:11 ET
|
Energias Market Research
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- The global traumatic brain injuries treatment market is expected to grow steadily from USD 112.6 billion in 2017 to USD 156.8 billion in 2024, at a CAGR...
Endonovo Therapeutics Announces Complimentary New Product
November 08, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Provides Update on Liver Study
October 22, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
June 14, 2018 08:30 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...
Story of Traumatic Brain Injury Wins #IAmInvisibleNoMore Video Contest
May 04, 2018 17:10 ET
|
Allsup
Belleville, Illinois, May 04, 2018 (GLOBE NEWSWIRE) -- The Invisible Disabilities Association (IDA), an organization dedicated to raising worldwide awareness of invisible disabilities, and Allsup,...
Arizona Legislature Approves Hyperbaric Oxygenation Treatment for Veterans with Traumatic Brain Injury, Reports the Association of American Physicians and Surgeons (AAPS)
April 02, 2018 12:57 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., April 02, 2018 (GLOBE NEWSWIRE) -- Veterans with traumatic brain injuries (TBI) and selected post-traumatic stress disorder (PTSD) conditions would be eligible to participate in...
Neuroscientists Adopting Huron TissueScope Whole Slide Scanning Platform to Accelerate Brain Research
October 31, 2017 09:53 ET
|
Huron Digital Pathology
Waterloo, Canada, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Waterloo, Ontario, Canada – October 31, 2017 – With the Neuroscience 2017 conference in Washington fast approaching, Huron Digital Pathology, a...